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Estimating Multiparameter Partial Expected
Value of Perfect Information from
a Probabilistic Sensitivity Analysis Sample:
A Nonparametric Regression Approach
Mark Strong, PhD, Jeremy E. Oakley, PhD, Alan Brennan, PhD
The partial expected value of perfect information (EVPI)
quantifies the expected benefit of learning the values of
uncertain parameters in a decision model. Partial EVPI is
commonly estimated via a 2-level Monte Carlo procedure
in which parameters of interest are sampled in an outer
loop, and then conditional on these, the remaining parame-
ters are sampled in an inner loop. This is computationally
demanding andmay be difficult if correlation between input
parameters results in conditional distributions that are hard
to sample from. We describe a novel nonparametric regres-
sion-based method for estimating partial EVPI that requires
only the probabilistic sensitivity analysis sample (i.e., the set
of samples drawn from the joint distribution of the
parameters and the corresponding net benefits). The
method is applicable in a model of any complexity and
with any specification of input parameter distribution. We
describe the implementation of the method via 2 nonpara-
metric regression modeling approaches, the Generalized
Additive Model and the Gaussian process. We demonstrate
in 2 case studies the superior efficiency of the regression
method over the 2-level Monte Carlo method. R code is
made available to implement the method. Key words: value
of information; expected value of perfect information; eco-
nomic evaluation model; nonparametric regression; Bayes-
ian decision theory; computational methods. (Med Decis
Making 2014;34:311–326)
Health economic decision analytic models areused to estimate the expected net benefits of competing decision options. The true values of theinput parameters of such models are rarely known
with certainty, and it is often useful to quantify the
value to the decision maker of reducing uncertainty
about the model input parameters. The value of
learning an input parameter (or a group of input
parameters) can be quantified by its partial expected
value of perfect information (partial EVPI).1–4 The
partial EVPI value for an input parameter reveals
the sensitivity of the decision to our uncertainty
about that input parameter, and as such can be used
to inform the design and prioritization of future
research.
The partial EVPI for a single parameter (or group of
parameters) of interest is typically calculated via a 2-
level nested Monte Carlo approach. This requires us
to sample values of the input parameter(s) of interest
in an outer loop and then to sample values from the
joint conditional distribution of the remaining
parameters and run the model in an inner loop.5,6
We recognize 3 important limitations to this method.
First, the 2-levelmethod is computationally demand-
ing for all but very simple models because of the
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nested loop scheme. Second, the approach requires
that the model is run as part of the EVPI calculation
process, which may be difficult in certain software
applications. Last, a potential problem arises in cases
inwhich correlations exist between parameters. If the
parameters of interest are correlated with the remain-
ing parameters, then for the 2-level Monte Carlo
method to work, there must be some method of sam-
pling from the distribution of the remaining parame-
ters, conditional on the values of the parameters of
interest that have been sampled in the outer loop. If
the required conditional distributions are difficult
to sample from, say requiring Markov chain Monte
Carlo (MCMC), then the computational burden will
be substantially further increased.
Our experience is that although probabilistic sen-
sitivity analyses (PSA) have become the norm in
many economic evaluations for health technology
assessment across the world, it is much less common
for partial EVPIs to be estimated. In our view, the rea-
sons for this are partly technical (in terms of the extra
demands on the statistical and programming skills of
the analyst), partly computational (the additional
model development and model running time to
implement 2 nested loops rerunning the model on
each iteration), and partly structural (in that decision
makers and research funding bodies have not always
demanded these analyses).
The following scenario is typical of the kinds of
problems we have encountered. A probabilistic sen-
sitivity analysis sample (i.e., a set of sampled input
parameters with their corresponding model outputs)
has been generated for a patient-level simulation
model. Each PSA run has required in the order of
tens of thousands of patient-level runs of the simula-
tion model to achieve convergence, with consider-
able computational cost. The analyst now wishes to
estimate the partial EVPI value for a subset of input
parameters (e.g., those that relate to clinical efficacy).
Parameters within this subset of interest may be cor-
related with other input parameters. To achieve the
partial EVPI calculation via the 2-level partial EVPI
scheme might then have a computational cost of
1000 outer loops times 1000 inner loops times
10 000 runs of the patient-level simulation model
(i.e., 1011 model evaluations in total). Not surpris-
ingly, such calculations are often considered too
computationally costly.
Recently, computationally efficient methods for
calculating partial EVPI have been published,7,8 but
these work only when we require the partial EVPI
for each model parameter separately. This restriction
to single parameters is potentially problematic
because we often expect research to update our
knowledge about groups of parameters (for example,
a set of relative risks or a group of related costs) rather
than just single parameters.
In this article, we present a nonparametric regres-
sion-based method for calculating partial EVPI that
overcomes the 3 limitations above and can be used
to evaluate the partial EVPI of any subset of model
parameters without rerunning the model. The article
is structured as follows. In the second section, we
introduce the nonparametric regression method and
describe its general application. In the third section,
we demonstrate the method in 2 case studies. In
both of our case studies, we assume we have only
a single PSA sample but wish to calculate the partial
EVPI values of several sets of parameters of interest.
The first case study is based on amodel that is simple
in structure but in which there are correlations
between inputs. The second case study is amore com-
plex Markov model. Both models have been used
before for illustrative purposes.5,7,9,10 In the fourth
section, we conclude with a discussion of the impli-
cations and limitations of the approach.
METHOD
Partial EVPI
The partial expected value of information is the
expected difference between the value of the optimal
decision based on perfect information about those
inputs and the value of the decision made only with
prior information. To express this, we introduce
some notation.
We assume that we are faced with D decision
options, indexed d51; . . . ;D, and have built amodel
NBðd;xÞ that aims to predict the net benefit of deci-
sion option d given a vector of r input parameter val-
ues, x5 ðx1; . . . ; xrÞ.
The true values of the input parameters are
assumed to be unknown. We denote the true but
unknown parameter values as upper case
X5 ðX1; . . . ;XrÞ and a sample drawn from the joint
distribution of the parameters as x5 ðx1; . . . ; xrÞ. We
denote the vector of p input parameters for which we
wish to calculate thepartial EVPI asXi and the remain-
ing r p input parameters as Xi. We denote the
expectation over the full joint distribution of X as
EX, over the marginal distribution of Xi as EXi , and
over the conditional distribution of XijXi as EXijXi .
The expected value of our optimal decision, made
only with current information, is
STRONG AND OTHERS
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max
d
EXfNBðd;XÞg: ð1Þ
If we knew the value of the inputs of interest, Xi,
then the optimal decision would be that with the
greatest net benefit, after averaging over the condi-
tional distribution of the remaining unknown inputs
XijXi. The expected net benefit would be
max
d
EXijXi NBðd;Xi;XiÞf g: ð2Þ
But, because Xi is unknown, we must average over
our current information about Xi, giving
EXi max
d
EXijXi NBðd;Xi;XiÞf g
 
: ð3Þ
The partial EVPI for inputs Xi is the difference
between Equation 3, the expected value of the deci-
sion made with perfect information about Xi, and
Equation 1, the expected value of the current optimal
decision option,3,4
EVPIðXiÞ5EXi max
d
EXi jXi NBðd;Xi;XiÞf g
 
max
d
EXfNBðd;XÞg: ð4Þ
We are commonly in a situation in which we
cannot evaluate any of the 3 expectations in Equation
4 analytically. Important exceptions are cases in
which models are either of linear form (e.g.,
Y5b1X11b2X2) or multilinear (sum-product) form
(e.g., Y5b1X1X21b2X3X4; where b1 and b2 are con-
stants). In the linear case, both the expectation in Equa-
tion 1 and the inner expectation in Equation 3 have an
analytic solution, and in the multilinear case, these
expectations have an analytic solution if inputs are
independent.11 In the case of correlated inputs, ana-
lytic solutions to these 2 expectations will sometimes
exist, such as the case in which the inputs have a mul-
tivariate Normal distribution. The outer expectation in
Equation 3 ismore problematic because of themaximi-
zation step, and analytic solutions rarely exist. See
Brennan and others for a fuller discussion.5
A PSA takesN samples from the joint distribution
of the input parameters, fxð1Þ; . . . ;xðNÞg, and gener-
ates a corresponding set of N net benefits,
fNBðd;xð1ÞÞ; . . . ;NBðd;xðNÞÞg, for each decision
option d. From this, the Monte Carlo solution to
the second term in Equation 4 is simply
maxd
1
N
PN
n5 1NBðd;xðnÞÞ.
The first term in Equation 4 requires more work,
and unless there are analytic solutions to the expect-
ations, the usual approach is to use a nested 2-level
Monte Carlo method with K ‘‘outer’’ simulations
and J ‘‘inner’’ simulations.11 Here, the estimator is
given by
1
K
XK
k5 1
max
d
1
J
XJ
j5 1
NB d;x
ðkÞ
i ;x
ðj; kÞ
i
 
; ð5Þ
where x
ðj; kÞ
i are samples drawn from the conditional
distribution XijXi5xðkÞi .
Sufficient numbers of runs of both the outer and
inner loops are required to ensure that the partial
EVPI is estimated with sufficient precision and with
an acceptable level of upward bias that is induced
by the maximization step. For models that are slow
to run, this 2-level scheme can represent a consider-
able computational burden.
To address the problems of the 2-level method, we
focus our attention on the estimation of the inner
expectation. To avoid the need for the inner loop sim-
ulation, we reframe the estimation of this conditional
expectation as a regression problem.
Principles of Estimating Partial EVPI Using
Regression
Our target is to estimate the conditional expecta-
tion EXijXi5xifNBðd;xi;XiÞg evaluated at some par-
ticular value xi, because given this, the partial EVPI is
easily obtained. To estimate this conditional
expected net benefit, we undertake 3 conceptual
moves.
First, we recognize that we can express the model
output for model run n as a sum of the conditional
expectation that we require, and a mean-zero error
term,
NBðd;xðnÞÞ5E
XijXi5xðnÞi
fNBðd;xðnÞi ;XiÞg1 eðnÞ: ð6Þ
To seewhy the error termmust have zeromean, we
rearrange and take expectations,
EðeÞ5EfNBðd;XÞg  EXi ½EXijXi5xifNBðd;xi;XiÞg
5EfNBðd;XÞg  EfNBðd;Xi;XiÞg
5EfNBðd;XÞg  EfNBðd;XÞg5 0:
ð7Þ
The second move is to realize that the expectation
E
XijXi5xðnÞi
fNBðd;xðnÞi ;XiÞg takes a different value
for each value x
ðnÞ
i and can therefore be thought of
as a function of xi. We do not know the form of
this function, but we can denote it as the unknown
function gðd;xiÞ, allowing us to write for the nth
model run
PARTIAL EVPI VIA NONPARAMETRIC REGRESSION
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NBðd;xðnÞÞ5 gðd;xðnÞi Þ1 eðnÞ: ð8Þ
The third key idea is that we can treat theN model
outputs from the probabilistic sensitivity analysis
fNBðd;xð1ÞÞ; . . . ;NBðd;xðNÞÞg as ‘‘noisy’’ data
through which we can learn about the functional
form of gðd;xiÞ. Within Equation 8, we know
n5 1; . . . ;N values for the left-hand side NBðd;xðnÞÞ
and the corresponding n5 1; . . . ;N values of the
x
ðnÞ
i , and therefore, we can think of this as a regression
problem. However, we immediately recognize that
the target function gðd;xiÞ has unknown form, and
we have no desire to impose any particular form.
We could begin by fitting a standard linear model
with power and interaction terms to model the non-
linearity between the net benefits and the inputs of
interest, but we choose instead to adopt a more flexi-
ble nonparametric regression approach.
As an illustration, Figure 1 shows the results from
a hypothetical PSA in which we plot the net benefit
function, NBðx1; x2; x3Þ, against a single parameter of
interest, x1. The scatter of points suggests some kind
of U-shaped function. The dashed line shows a non-
parametric regression of NBðx1; x2; x3Þ on x1. This
regression provides an estimate of the expected value
EX2;X3jX15 x1NBðx1;X2;X3Þ as a function of x1, that is,
it provides the gðd;xiÞ from Equation 8. In this
particular illustrative model, the expectation
EX2;X3jX15 x1NBðx1;X2;X3Þ can be obtained analyti-
cally (solid line), showing that the true expectation is
very well estimated by the nonparametric regression.
Once we have obtained the regression function
estimate, g^ðd;xÞ, for each decision option in our eco-
nomic model, we can proceed to calculating the par-
tial EVPI. Evaluating g^ðd;xÞ at fxð1Þi ; . . . ;xðNÞi g gives
us fg^ðd;xð1Þi Þ; . . . ; g^ðd;xðNÞi Þg, which are the estimates
of the conditional expectations that we require, and
hence we can compute the partial EVPI by
dEVPIðXiÞ5 1
N
XN
n5 1
max
d
g^ðd;xðnÞi Þ max
d
1
N
XN
n5 1
g^ðd;xðnÞi Þ:
ð9Þ
Note that we use maxd
1
N
PN
n5 1 g^ðd;xðnÞi Þ as our
Monte Carlo estimator of the second term in Equation
4 rather than maxd
1
N
PN
n5 1NBðd;xðnÞÞ. By choosing
this as our estimator, we exploit the positive correla-
tion between the 2 terms in Equation 9 andhence esti-
mate the partial EVPI with increased precision.
We also note at this point that EVPI (calculated by
any method) is invariant to the reexpression of net
benefits as incremental net benefits, relative to
some chosen baseline option (which is therefore
defined as having an absolute net benefit of zero).
This reduces the number of regression problems
from D to D 1.
In the next sections, we give an overview of 2 partic-
ularnonparametric regressionmethods that are suitable
in this context, Gaussian process regression and regres-
sion based on a Generalized Additive Model (GAM).
GAM Regression
When we adopt a GAM, we represent the unknown
function gðd;xiÞ as the sumof a set of smooth functions
of the inputs. In the simplest form of GAM, we have
NBðd;xÞ5 gðd;xiÞ1 e;
gðd;xiÞ5 s1ðx1Þ1 . . . 1 spðxpÞ; ð10Þ
where each smoothing function sjðxjÞ is a function of
one of the j51; . . . ;p model input parameters of
interest, and e is a mean-zero Normally distributed
error with constant variance. For an introduction to
GAMmodels, see Hastie and Tibshirani12 orWood.13
The usual choice for the smoothing functions is
some form of spline, a common choice being the
cubic spline. A cubic spline represents an arbitrary
smooth function as a series of short cubic polyno-
mials joined piecewise, as shown in Figure 2.
Figure 1. Net benefit against single input parameter of interest for
hypothetical model with 3 parameters.
STRONG AND OTHERS
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The cubic spline shown in Figure 2 can also be
expressed as the weighted sum of a series of polyno-
mial basis functions, blðxÞ, that take values of x across
the whole range of x, rather than values in short seg-
ments of the range of x (this builds up the spline func-
tion in a manner similar to the way in which an
arbitrary soundwave can be built up from sine waves
of increasing frequency). This allows us to write
y5 sðxÞ5
XL
l5 1
blblðxÞ; ð11Þ
for some basis dimension L. The basis dimension con-
trols thedegree towhich the spline canbe ‘‘wiggly’’ (we
can loosely think of this as akin to determining the
number of segments in Figure 2). The basis functions
themselves tend to be cumbersome to write out, and
the reader is referred to Wood for further details.13
By expressing our unknown function (Equation
10) in the same way, we get
gðd;xiÞ5
XL1
l15 1
bl1bl1ðx1Þ1 . . . 1
XLp
l5 1p
blpblpðxpÞ: ð12Þ
Estimation of the model coefficients is typically
via penalized maximum likelihood, in which the
penalties are designed to suppress overly wiggly esti-
mates that would result in overfitting. The choice of
basis dimension for each spline is usually not impor-
tant as long as it is sufficiently large to avoid con-
straining the spline to be overly inflexible (we
found any any dimension greater than 3 to be suffi-
cient). In practice, the software in which GAM is
implemented makes the choice of basis dimension
for each spline automatically.
Although the simple additive model in Equation
10 performs well in many situations, it will not ade-
quately capture interactions between the input
parameters of interest that may be a feature of the
health economic model. To model interactions, we
must include multivariate smoothing functions in
our GAM model specification. So, for example, if
we expect there to be interactions between inputs x1
and x2, then we would specify the model
gdðxiÞ5 s1ðx1; x2Þ1 s2ðx3Þ; . . . ; sp1ðxpÞ: ð13Þ
The multivariate smoothing function s1 is built up
using a tensor product construction, which results in
the spline’s being the sumof allmultiplicative combi-
nations of the basis functions for each variable,
s1ðx1; x2Þ5
XL1
l15 1
XL2
l25 1
bl1l2bl1ðx1Þbl2ðx2Þ: ð14Þ
Modeling a large number of potential interactions
does therefore have a cost. Given m inputs that are
expected to interact in the economic model, and
assuming the same basis dimension, n, for each input
variable, the GAM model must estimate nm coeffi-
cients. If nm approaches the size of the PSA sample,
then the GAM method will break down. This is one
motivation for the more flexible Gaussian process
regression approach described in the next section.
After estimating the GAM model parameters and
hence obtaining g^ðd;xÞ, we can evaluate g^ðd;xÞ at
the PSA inputs to give fgðd;xð1Þi Þ; . . . ; gðd;xðNÞi Þg and
therefore the partial EVPI via Equation 9. The code
in Box 1 illustrates the simplicity of the GAM regres-
sion approach using the mgcv package in R.14 In the
example, there are 2 decision options, with the vector
object INB holding the incremental net benefits from
the PSA. The PSA samples from the 2 parameters of
interest are held in vector objects x5 and x14. We
assume the parameters do not interact in the model.
If they did, we would simply replace the model for-
mula INB ; s(x5)1 s(x14) with the tensor product
multivariate specification INB ; te(x5,x14).
Box 1 Example R Code for Estimating Partial
Expected Value of Perfect Information via
Generalized Additive Model Regression
library (mgcv)
model\- gam(INB ~ s(x5)1s(x14))
g.hat\- model$fitted
partial.evpi\- mean(pmax(0,g.hat)) -
max(0,mean(g.hat))
Figure 2. A cubic spline, showing the piecewise construction from
4 sections of cubic polynomial, each with different coefficients.
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A method for estimating the standard error of the
GAM-based approximation of the partial EVPI is
given in Appendix A. R functions for computing the
partial EVPI via GAM and its standard error are avail-
able at http://www.shef.ac.uk/scharr/sections/ph/
staff/profiles/mark.
Gaussian Process Regression
The Gaussian process is a highly flexible represen-
tation of an unknown function, in our case gðd;xiÞ,
that again requires no parametric assumptions
regarding functional form.15 When we model the
function gðd;xiÞ as a Gaussian process, we assume
that we can represent the unknown values of the
function evaluated at the PSA inputs,
fgðd;xð1Þi Þ; . . . ; gðd;xðNÞi Þg, via a multivariate Normal
distribution. To be more precise, we are representing
our beliefs about the function using the multivariate
Normal distribution. The function itself is unknown.
We will therefore require a method for specifying the
mean, variance, and covariance of the distribution
that specifies our beliefs about the unknown function
gðd;xiÞ given the PSA values fxð1Þ; . . . ;xðNÞg and
fNBðd;xð1ÞÞ; . . . ;NBðd;xðNÞÞg that we have observed
(sampled).
It is very important to note that by representing the
unknown function gðd;xiÞ as a Gaussian process, we
do not require that the model input parameters xi are
Normally distributed (Gaussian) or that the net bene-
fits NBðd;xÞ are Gaussian. In practice, the main
requirement is that gðd;xiÞ is a smooth function of
its inputs in the sense that for any x
ðnÞ
i and x
ðmÞ
i that
are close, gðd;xðnÞi Þ and gðd;xðmÞi ) are also close. This
is a weak requirement and likely to hold in most
health economic models because costs and health
benefits (e.g., quality-adjusted life-years [QALYs])
are usually continuous functions of the uncertain
model input parameters.
Until now, the use of the Gaussian process in
health economics has been rare and restricted to the
modeling of the net benefit function in the context
of a computationally expensive model.16–18 For
a practical introduction to building Gaussian process
models, see the Managing Uncertainty in Complex
Models toolkit at mucm.aston.ac.uk/MUCM/MUCM-
Toolkit/.
Gaussian Process Regression Model Specification.
Recall that our PSA sample consists of N input vec-
tors fxð1Þ; . . . ;xðNÞg and N corresponding net bene-
fits fNBðd;xð1ÞÞ; . . . ;NBðd;xðNÞÞg for each decision
option d. For each model run n5 1; . . . ;N, we
have NBðd;xðnÞÞ5 gðd;xðnÞi Þ1 eðnÞ from Equation 8.
We assume that the vector of unknown values of
the function gðd;xiÞ evaluated at the PSA input val-
ues, fgðd;xð1Þi Þ; . . . ; gðd;xðNÞi Þg, jointly follows a mul-
tivariate Normal distribution,
fgðd;xð1Þi Þ; . . . ; gðd;xðNÞi Þg;NðHb;s2SÞ: ð15Þ
The mean of the distribution Hb is a vector of
lengthN and is the matrix product of a design matrix
H5
1 x
ð1Þ
1 . . . x
ð1Þ
p
1 x
ð2Þ
1 . . . x
ð2Þ
p
..
. ..
. ..
. ..
.
1 x
ðNÞ
1 . . . x
ðNÞ
p
0BBBB@
1CCCCA ð16Þ
of sizeN3 q, (where q5p11Þ, and a vector of regres-
sorsb5 ðb1; . . . ;bqÞ. The covariancematrix is a prod-
uct of a scalar variance term s2 and a correlation
matrix S of size N3N.
We require that the correlation matrix S describes
the smoothness of the function gðd;xiÞwith respect to
each input parameter of interest in the set of p inputs
thatmakes upxi.We therefore define the fn;mgth ele-
ment of S to be a function of the p input parameters of
interest in the following way,
S
ðn;mÞ5 exp 
Xp
j5 1
fðxðnÞj  xðmÞj Þ=djg
2
" #
: ð17Þ
The superscripts ðnÞ and ðmÞ denote arbitrary runs
in the PSA sample, and j indexes the p parameters of
interest that make up xi. The correlation length
hyperparameters dj describe the smoothness of
gðd;xiÞ with respect to each parameter of interest
and are estimated from the PSA sample as described
below.
Note that the form of the correlation function
ensures that diagonal entries in thematrixS are equal
to 1 as they should be for a valid correlation matrix.
To see why, observe that on the diagonal, we have
Sðn;nÞ5 exp Ppj5 1 fðxðnÞj  xðnÞj Þ=djg2h i5 exp ð0Þ5 1.
The value of Sðn;mÞ, and therefore the correlation
between gðxðnÞi Þ and gðxðmÞi Þ, decreases toward zero
as the distance between x
ðnÞ
i and x
ðmÞ
i increases,
with the values of dj controlling how fast this decay
to zero occurs.
Finally, we require a method for learning about b,
s2, and dj from the net benefits, NBðd;xÞ. To do this,
we must link the Gaussian process model for gðd;xiÞ
to the net benefits, NBðd;xÞ. Recalling Equation 8, the
STRONG AND OTHERS
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net benefit obtained on the nth PSA model run,
NBðd;xðnÞÞ, is considered to be the sum of gðd;xðnÞi Þ
and a noise term eðnÞ, which implies that we can
write
fNBðd;xð1ÞÞ; . . . ;NBðd;xðNÞÞg;NfHb;s2ðS1 nIÞg; ð18Þ
where I is the identity matrix of size N and n is a
‘‘nugget’’ term that controls the variance of a
Normally distributed mean zero, constant variance
noise term e.19,20 For compactness of notation in
the remainder of the article, we write S5S1 nI
and define the vectors nbd5 fNBðd;xð1ÞÞ; . . . ;NB
ðd;xðNÞÞg, gd5 fgðd;xð1Þi Þ; . . . ; gðd;xðNÞi Þg, and g^d5
fg^ðd;xð1Þi Þ; . . . ; g^ðd;xðNÞi Þg.
Estimation of Hyperparameters b, s2, dj, and n.
The first step is to estimate the correlation lengths
dj and the nugget term n from the PSA sample. The
most straightforward approach is to find the valuesbdj and bn that maximize the joint posterior density
of dj and n given the net benefits nbd. This requires
numerical methods, and details are given in Appen-
dix B. An R function is available at http://www.shef
.ac.uk/scharr/sections/ph/staff/profiles/mark. Givenbdj and bn (and hence S), the posterior mean of b,
which can be derived analytically, is
b^5 ðHTS1HÞ1HTS1nbd ð19Þ
and the posterior mean of s2 is
bs25 ðnbd Hb^ÞTS1ðnbd Hb^Þ
n q 2 : ð20Þ
Estimation of gðd;xiÞ. Once we have determined S
and b^, we can use the properties of the Normal dis-
tribution to obtain the expected value of gd condi-
tional on the net benefits nbd,
g^d5Hb^1SS
1ðnbd Hb^Þ: ð21Þ
The components of g^d are fg^ðd;xð1Þi Þ; . . . ;
g^ðd;xðNÞi Þg and hence can be plugged into Equation
9 to give the partial EVPI. A method for estimating
the standard error of the Gaussian process regression
approximation for the partial EVPI is given inAppen-
dixA. TheR code for computing theGaussian process
regression-based partial EVPI and its standard error is
available at http://www.shef.ac.uk/scharr/sections/
ph/staff/profiles/mark.
Implementation Issues and Regression Diagnostics
We recommended above that net benefits are
expressed as incremental net benefits, relative to
a chosen baseline option. This not only reduces the
number of regression problems from D to D 1 but
also improves numerical stability, particularly for
the Gaussian process method. For the same reason,
we also suggest that, for the Gaussian process
method, the input parameters of interest are each
scaled to lie in the ½0; 1 interval. This ensures that
the smoothness parameters dj are estimated on a com-
mon scale. EVPI is invariant to linear rescaling of the
input parameters.
For both Gaussian process and GAM models,
examination of the residuals is useful for assessing
the robustness of assumptions. A plot of residuals
(i.e., yd  g^d) against fitted values (g^d) allows assess-
ment of the mean-variance relationship and will
highlight deviation from the assumption of constant
variance. A Normal quantile-quantile plot of resid-
uals will show deviation from the assumption of Nor-
mality of the residuals.
CASE STUDIES
Case Study 1: A Simple Decision Tree Model with
Correlated Inputs
Case study 1 is based on a hypothetical decision
tree model previously used for illustrative purpo-
ses.5,7,9,10 The model predicts net benefit, NBðd;xÞ,
under 2 decision options (d5 1;2) and can be written
in sum product form as
NBð1;xÞ5 lðx5x6x71 x8x9x10Þ  ðx11 x2x3x4Þ; ð22Þ
NBð2;xÞ5 lðx14x15x161 x17x18x19Þ  ðx111 x12x13x4Þ;
ð23Þ
where x1; . . . ; x19 are sampled realizations of the
uncertain input parameters X1; . . . ;X19 listed in
Table 1, and thewillingness to pay for 1 unit of health
output in QALYs is l5 10; 000=QALY. Note that
some components of x5 ðx1; . . . ; x19Þ are redundant
in NBðd;xÞ for each d.
We assume that our uncertainty about the inputs
can be represented by amultivariate Normal distribu-
tion, with X5, X7, X14, and X16 all pairwise correlated
with a correlation coefficient of 0.6, and with X6 and
x15 correlated with a correlation coefficient of 0.6. All
other inputs were assumed independent. In a simple
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sum product form model, the assumption of multi-
variateNormality allowsus to compute the inner con-
ditional expectation analytically.
We define 3 parameter sets of interest: set 1 com-
prising effectiveness parameters X5 and X14, repre-
senting information that could be gained from
a trial; set 2 comprising effectiveness and utility
parametersX5;X6;X14 andX15, representing informa-
tion that could be gained from a trial that also col-
lected utility data; and set 3 comprising duration of
response parameters X7 and X16, representing infor-
mation that could be gained from the long-term fol-
low-up of trial participants.
Although the case study model is computationally
cheap to evaluate, we assume thatwe are in a position
of being able to evaluate the model only 10 000 times.
Given this limitation, we calculated partial EVPI
using 3 methods. First, we calculated the partial
EVPI for eachparameter set using a single-loopMonte
Carlo approximation for the outer expectation in the
first term of the right-hand side of Equation 4 with
10 000 samples from the distribution of the parame-
ters of interest, an analytic solution to the inner con-
ditional expectation, and hence 10 000 model runs.
Next, we calculated the partial EVPI values using
the standard 2-levelMonte Carlo approachwith 3 dif-
ferent sets of J inner loop samples and K outer loop
samples, where J3K = 10 000 model runs in total
(see Table 2 for values of J and K). Third, we com-
puted the partial EVPI values using the GAM regres-
sion method with a total of 10 000 PSA samples.
Finally, we computed the partial EVPI values using
the Gaussian process regression method with the
same 10 000 PSA samples.
We compared valueswith a gold standardmeasure
of partial EVPI calculated using the analytic solution
to the inner conditional expectation, and 107 outer
loop samples. Standard errors for the 2-level Monte
Carlo partial EVPI estimates were obtained using
themethod given in Appendix A. Estimates of partial
EVPI using the 2-level Monte Carlo method are
upwardly biased for small values ofJ, due to themax-
imization step. The estimates of upward bias were
obtained using the method presented in Oakley and
others9 (see Appendix A).
For eachmethod, we report the mean time taken to
compute the partial EVPI for the 3 parameter sets of
interest.
Results for Case Study 1. Regression diagnostic
plots for the Gaussian process and GAM models
are shown in Figure 3. A random subset of 500
points is shown on each plot. First of note is, for
each parameter set, the similarity in the pattern of
residuals between the Gaussian process model and
the GAM model (reflecting the similarity in esti-
mates of g). In each case, the plots of residuals
against fitted values show no worrying heterosce-
dasticity, and the residual Normal Q-Q plots show
no gross deviation from Normality.
Figure 4 shows the values of g^ obtained via the
regression methods against the analytically calcu-
lated values of g. Good agreement is seen over the
whole range.
Table 2 shows the estimated partial EVPI values for
the 3 sets of parameters of interest. The overall EVPI
for all 19 parameters is £1047. The top line shows
the gold standard estimates, obtained by generating
107 samples from the joint distribution of the inputs
of interest and then analytically calculating the
expected net benefits for each decision option, condi-
tional on these sampled values. The standard errors
of the gold standard estimates are small. When we
restrict ourselves to only 10 000 model evaluations,
Table 1 Summary of Means and Standard Deviations for Case Study Model Parameters
Mean (sd)
Parameter d51 d52
Cost of drug ðX1;X11Þ, £ 1000 (1) 1500 (1)
% Admissions ðX2;X12Þ 10 (2) 8 (2)
Days in hospital ðX3;X13Þ 5.20 (1.00) 6.10 (1.00)
Cost per day ðX4Þ, £ 400 (200) 400 (200)
% Responding ðX5;X14Þ 70 (10) 80 (10)
Change in utility if respond ðX6;X15Þ 0.30 (0.10) 0.30 (0.05)
Duration of response ðX7;X16Þ, years 3.0 (0.5) 3.0 (1.0)
% Side effects ðX8;X17Þ 25 (10) 20 (5)
Change in utility if side effect ðX9;X18Þ –0.10 (0.02) –0.10 (0.02)
Duration of side effect ðX10;X19Þ, years 0.50 (0.20) 0.50 (0.20)
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but again use the analytic solution to the conditional
expectation, the standard errors are unsurprisingly
larger. The estimates are still unbiased. In contrast,
estimates obtained via the 2-level Monte Carlo
approach are biased due to the maximization
over quantities that are subject to sampling variabil-
ity.9 When restricted to 10 000 model evaluations,
there is a clear tradeoff between bias and variance
when using the 2-level method, with small values
of the inner loop resulting in considerable upward
bias.
In comparison, the regression-based estimates all
have lower variance than any of the 2-level
Monte Carlo estimates when model runs are
restricted to 10 000. The upward bias due to themax-
imization in the first term of Equation 9 is small in
each case and comparable with that obtained by
the 2-level Monte Carlo method with 1000 inner
loop samples. To achieve a similar level of bias
and variance to that obtained using the regression
method with 104 PSA samples, the 2-level Monte
Carlo would require approximately 107 model
runs.
The computational cost of obtaining the gold stan-
dard estimate is greatest, because of the large sample
size. The 2-level Monte Carlo method is fast in this
example because of the simplicity of the model but
will typically be slower and will increase as the com-
putational complexity of themodel increases. In con-
trast, the speeds of the Gaussian process and GAM
methods are independent of the computational
complexity of the model because the model itself is
not evaluated during the regression fitting process.
The GAMmethod takes less than 1 s with a PSA sam-
ple size of 104, whereas the Gaussian process method
takes approximately 3 min.
Case Study 2: Three State Markov Model
Case study 2 is an extension of the case study 1
model that incorporates a 20-time cycle Markov
model for the response to each intervention. The
parameters for mean duration of response (x7 and
x16) are replaced with Markov models of natural his-
tory of response to each drug with health states
‘‘responding,’’ ‘‘not responding,’’ and ‘‘dead.’’ The
model is
NBð1;xÞ5 l
X20
n5 1
ST1M
n
1U1
 
1 x8x9x10
( )
 ðx11 x2x3x4Þ;
ð24Þ
NBð2;xÞ5l
X20
n51
ST2M
n
2U2
 
1 x17x18x19
( )
 ðx111 x12x13x4Þ;
ð25Þ
where the vectors Sd and Ud are defined as
S15 ðx5; 1 x5;0ÞT, S25 ðx14;1 x14;0ÞT, U15 ðx6;
0; 0ÞT, and U25 ðx15; 0; 0ÞTand where the transition
matrices are defined as
Table 2 Partial Expected Value of Perfect Information (EVPI) Values and Timings for Case Study 1
Sample Size Partial EVPI (SE; Upward Bias), £
Outer Loop Inner Loop Total Parameter Set 1 fX5;X14g Parameter Set 2 fX5;X6;X14;X15g Parameter Set 3 fX7;X16g Mean Time
One-level Monte Carloa
107 — 107 247.95 (0.14; unbiased) 840.84 (0.27; unbiased) 536.28 (0.31; unbiased) 1.3 h
One-level Monte Carlob
104 — 104 255.15 (4.41; unbiased) 845.73 (8.53; unbiased) 534.80 (9.01; unbiased) 1.0 s
Two-level Monte Carlob
101 103 104 232.80 (140.28; 1.42) 474.22 (452.56; 0.17) 301.55 (269.00; 0.42) 0.04 s
102 102 104 222.75 (49.34; 14.28) 796.77 (143.94; 1.83) 501.51 (86.71; 5.88) 0.07 s
103 101 104 351.92 (25.20; 130.69) 909.06 (47.95; 20.35) 583.05 (32.46; 62.99) 0.5 s
Two-level Monte Carloc
104 103 107 243.61 (4.37; 1.34) 834.73 (13.67; 0.25) 552.97 (9.13; 0.74) 34 s
Gaussian process regressionb
104 — 104 234.44 (17.02, 0.82) 830.48 (11.44, 0.65) 541.13 (15.76, 0.49) 170 s
GAM regressionb
104 — 104 234.52 (16.24, 1.76) 832.19 (10.48, 0.25) 540.50 (15.49, 0.51) 0.9 s
a. Reference gold standard.
b. Model runs restricted to 104.
c. J and K chosen to achieve SE and bias of the same order of magnitude as the regression estimates.
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M15
x20 x21 x22
x23 x24 x25
0 0 1
0@ 1A andM25 x26 x27 x28x29 x30 x31
0 0 1
0@ 1A: ð26Þ
Uncertainty regarding the transitionmatrix param-
eters (X20 toX31) was expressed using Dirichlet distri-
butions with ðX20;X21;X22Þ; Dirichlet(70,40,10);
ðX23;X24;X25Þ; Dirichlet(10,100,20); ðX26;X27;
X28Þ; Dirichlet(70,40,10); and ðX29;X30;X31Þ;
Dirichlet(10,100,20). Means and standard deviations
for the remaining input parameters are as for case
study 1 (Table 1), but now instead of assuming Nor-
mality for all parameters, we expressed our uncer-
tainty about X2;X5;X8;X12;X14 and X17 using Beta
distributions and our uncertainty about
X3;X4;X10;X13 and X19 using Gamma distributions.
In contrast with case study 1, it is assumed that
each input parameter X1 to X19 is independent of all
other parameters in the model.
We again defined 3 parameter sets of interest: set 1
comprising effectiveness parameters X5 and X14,
representing information that could be gained from
a trial; set 2 comprising effectiveness and utility
parameters X5;X6;X14 andX15, representing informa-
tion that could be gained from a trial that also col-
lected utility data; and set 3 comprising the
transition matrix parameters X20 to X31, representing
information that could be gained from the long-term
follow-up of trial participants.
Results for Case Study 2. A similar pattern of
results is seen for case study 2 as for case study 1.
Figure 3. Regression diagnostic plots for case study 1.
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Figure 4. Gaussian process and Generalized Additive Model regression predictions versus analytic values for case study 1.
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Regression diagnostic plots shown in Figure 5 are
similar in character to the those obtained in the first
case study, and again, no worrying departures from
the model assumptions are indicated.
Figure 6 shows the values of g^ calculated by the
regression methods against the corresponding values
obtained by the 2-level Monte Carlo method with 108
model runs (defined as our gold standard in this
case). Very good agreement is seen over the whole
range of g in each case.
Table 3 shows the estimated partial EVPI values.
The overall EVPI is £775. Standard errors for the
gold standard 2-level Monte Carlo estimates with
108 model runs are small, as are the values of the
upward bias. When the number of model evaluations
is restricted to 104, the regression methods perform
considerably better than the 2-level Monte Carlo
method, resulting in estimates that have both mini-
mal upward bias and substantially greater precision.
To achieve a similar level of bias and variance to that
obtained using the regression method with 104 PSA
samples, the 2-level Monte Carlo would require
approximately 107 model runs.
With a PSA sample size of 104, the GAM takes
approximately 1 s and the Gaussian process takes
approximately 3 min. In contrast, the 2-level Monte
Carlo method with 107 model runs takes 1.8 h.
DISCUSSION
Main Result and Implications
The regression-based approach we propose
requires only the single set of model evaluations
that is generated in a standard probabilistic sensitiv-
ity analysis to calculate partial EVPI for any set of
inputs. It leads to a considerable gain in precision
over the 2-level Monte Carlo method with the same
number of model runs while retaining an acceptably
small upward bias. The GAMmethod in particular is
straightforward to implement in the freely available
software R, thus allowing an analyst to compute par-
tial EVPI for any subset of input parameters quickly
and with relative ease.
The regression method allows the complete sepa-
ration of the EVPI calculation step from the model
evaluation step, which may be particularly useful
when the model has been built using specialist soft-
ware (e.g., for discrete event simulation) that does
not allow easy implementation of the EVPI step or
where those who wish to compute the EVPI do not
own (and therefore cannot directly evaluate) the
model. The method has the particular advantage
that, even in the case of correlated inputs, only the
joint distribution of inputs is required. This is in con-
trast to the 2-levelMonte Carlo approach inwhichwe
are required to sample values from pðXijXi5xiÞ, the
conditional distribution of the remaining parameters
given some sampled parameter vector of interest,
a process that an analyst could find challenging with-
out the necessary statistical training.
In terms of computational speed, the regression
methods are fast. We see 2 particular scenarios in
which this will be useful: when the analyst is faced
with a slow patient-level simulation model and in
the case in which the partial EVPI calculation would
require computationally demanding MCMC sam-
pling under the 2-level scheme.
For health economic decision analysts, the key
implication of the nonparametric regression
approach is that the computation of partial EVPI
has become tractable for any decision problem. We
hope that the computation of partial EVPI values
now becomes standard practice, and we urge those
who write guidance on good modeling practice to
promote the routine reporting of EVPI values.
Limitations
There are some limitations of the regression
approaches. In general, the GAM method will be
more straightforward to implement because of the
easy availability of software (e.g., the mgcv package
in R). However, if the set of input parameters forwhich
we wish to calculate partial EVPI is moderately large
(greater than 6 or so), and if it is expected that those
parameterswill jointly interact (nonadditively)within
the economic model, then it is likely that the number
of GAM model parameters that need to be estimated
will exceed the number of data points, causing the
method to fail. In this case, we would recommend
using the Gaussian process approach.
Although the Gaussian process method is rela-
tively easy to implement in R using the functions
available at http://www.shef.ac.uk/scharr/sections/
ph/staff/profiles/mark, the estimation of the hyper-
parameters requires numerical optimization, which
will be slow if the number of parameters of interest
is large. This optimization is not a black box proce-
dure, and as with other numerical methods such as
MCMC, the onus is on the user to ensure that conver-
gence is achieved. Second, the Gaussian process
method incurs the computational cost of inverting
the N3N matrix S, which increases in proportion
to N3, where N is the number of PSA samples. This
STRONG AND OTHERS
322  MEDICAL DECISION MAKING/APRIL 2014
 at Royal Hallamshire on April 8, 2014mdm.sagepub.comDownloaded from 
places a practical limit on the size of N (currently of
the order of tens of thousands), which in turn limits
the precision that can be achieved with the Gaussian
process method. Finally, the use of the Gaussian pro-
cess currently requires somewhat more work on the
part of the analyst than the GAM approach, even
with the functions that we have made available.
Using the Method in Patient-Level Models
In our introduction, we presented a typical sce-
nario in which obtaining partial EVPI via 2-level
Monte Carlowas likely to be computationally prohib-
itive due to the requirement to sample many thou-
sands of patients within each evaluation of the
inner loop.
Partial EVPI via the regression method is calcu-
lated for a patient-level model in the same manner
as it is for a cohort model (i.e., by regressing the
PSA sample net benefits on the parameters of inter-
est). We briefly recap here the computation of a PSA
for a patient-level model. This is a 2-level process
whereby samples are drawn from the PSA level
(i.e., population level) parameters in an outer loop,
and then, conditional on these samples, individual
patients are sampled in an inner loop. The purpose
of sampling individual patients is to average over het-
erogeneity (and/or uncertainty) at the patient level for
each sample of population-level input parameters.
Convergence is achieved when the patient-level sam-
ple size is large enough that, given some arbitrary
sample from the PSA (population)–level parameters,
Figure 5. Regression diagnostic plots for case study 2.
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Figure 6. Gaussian process and Generalized Additive Model regression predictions versus those obtained via the gold standard 2-level
Monte Carlo method for case study 2.
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the estimated net benefit is stable. Nonconvergence
will introduce additional noise in the estimation of
the net benefit for each sample from the PSAlevel
parameters.
Now, recall that in our approach, we treat all vari-
ability in the net benefit that is not due to the param-
eters of interest as noise (Equation 8). Any residual
variability due to nonconvergence of the patient-level
simulation will be treated as noise in the regression
and averaged out. Because the regression estimation
occurs before the maximization step, the residual
first-order uncertainty will not cause an upward
bias in the partial EVPI estimate.
Other Uses of the Gaussian Process in Health
Economic Decision Modeling
In our method, we modeled the target conditional
net benefit as an unknown smooth function of the
parameters of interest. The observed net benefits in
the PSA sample were treated as noisy data from
which to learn about the unknown function. This
use of a nonparametric regression method to approx-
imate the (conditional) output of a health economic
decision model is subtly different from the use of
the Gaussian process in previous work by Stevenson
and others,16 Tappenden and others,17 and Rojnik
and Naversnik.18 In these previous applications, the
Gaussian process was used to model the net benefit
itself as an unknown function of all the unknown
input parameters, rather than to model the
conditional net benefit as a function of the parameters
of interest only. The primary purpose for using the
Gaussian process was to construct a meta-model or
emulator for the health economic decision model to
allow a slowmodel to be replaced by a fast surrogate.
Although this approach reduces computation time,
the calculation of partial EVPI will typically still
require a nested 2-level Monte Carlo approach.
More importantly, this use of the Gaussian process
does not address the problemof sampling frompoten-
tially difficult conditional distributions if input
parameters are correlated.
Further Research
Although partial EVPI is useful in highlighting the
sensitivity of the decision to any particular subset of
input parameters, it represents only an upper bound
on the expected value of undertaking research to
reduce decision uncertainty. More useful is the
expected value of sample information (EVSI), which
represents the expected value of undertaking a partic-
ular data collection exercise.11 We are currently
working on extending the regression method
described above to the computation of EVSI.
Conclusion
In conclusion, the regression-based approach to
computing partial EVPI is likely to be of considerable
benefit over the traditional 2-level Monte Carlo
approach, except perhaps in models that are
Table 3 Partial Expected Value of Perfect Information (EVPI) Values and Timings for Case Study 2
Sample Size Partial EVPI (SE; upward bias), £
Mean TimeOuter Loop
Inner
Loop Total
Parameter
Set 1 fX5;X14g
Parameter
Set 2 fX5;X6;X14;X15g
Parameter
Set 3 fX20 to X31g
Two-level Monte Carloa
104 104 108 67.95 (1.43; 0.22) 587.14 (9.38; 0.03) 416.80 (6.50; 0.05) 17.7 h
Two-level Monte Carlob
101 103 104 5.77 (50.66; 2.01) 389.93 (296.6; 0.29) 178.93 (223.02; 0.39) 3.7 s
102 102 104 77.07 (21.96; 19.98) 661.75 (94.34; 2.40) 362.82 (71.78; 4.41) 2.9 s
103 101 104 228.32 (15.11; 148.24) 623.70 (31.43; 21.63) 467.61 (26.06; 42.32) 2.8 s
Two-level Monte Carloc
104 103 107 68.84 (4.47; 0.22) 595.14 (9.39; 0.13) 426.67 (6.51; 0.30) 1.8 h
GP regressionb
104 — 104 62.36 (10.35; 0.64) 582.32 (8.85; 0.13) 408.17 (10.30; 2.01) 198 s
GAM regressionb
104 — 104 62.53 (9.98; 0.47) 582.03 (8.23; 0.49) 409.80 (10.37; 1.03) 0.9 s
a. Reference gold standard.
b. Model runs restricted to 104.
c. J and K chosen to achieve SE and bias of the same order of magnitude as the regression estimates.
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computationally very cheap to evaluate and in which
there are no correlations in the inputs. With the
increasing use of patient-level micro-simulation
models, we envisage that obtaining partial EVPI via
the traditional 2-level Monte Carlo approach will be
considered just too time-consuming (in fact, experi-
ence suggests that the 2-level Monte Carlo procedure
is considered too difficult for evenmoderately simple
cohort models). In contrast, the regression methods
we have presented provide a mechanism for rapidly
estimating partial EVPI for any set of parameters in
a model of any complexity.
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